185 related articles for article (PubMed ID: 21576572)
1. Recurrence after treatment of nonmelanoma skin cancer: a prospective cohort study.
Chren MM; Torres JS; Stuart SE; Bertenthal D; Labrador RJ; Boscardin WJ
Arch Dermatol; 2011 May; 147(5):540-6. PubMed ID: 21576572
[TBL] [Abstract][Full Text] [Related]
2. Tumor recurrence 5 years after treatment of cutaneous basal cell carcinoma and squamous cell carcinoma.
Chren MM; Linos E; Torres JS; Stuart SE; Parvataneni R; Boscardin WJ
J Invest Dermatol; 2013 May; 133(5):1188-96. PubMed ID: 23190903
[TBL] [Abstract][Full Text] [Related]
3. Quality-of-life outcomes of treatments for cutaneous basal cell carcinoma and squamous cell carcinoma.
Chren MM; Sahay AP; Bertenthal DS; Sen S; Landefeld CS
J Invest Dermatol; 2007 Jun; 127(6):1351-7. PubMed ID: 17301830
[TBL] [Abstract][Full Text] [Related]
4. Defining recurrence of nonmelanoma skin cancer after Mohs micrographic surgery: Report of the American College of Mohs Surgery Registry and Outcomes Committee.
Leitenberger JJ; Rogers H; Chapman JC; Maher IA; Fox MC; Harmon CB; Bailey EC; Odland P; Wysong A; Johnson T; Wisco OJ
J Am Acad Dermatol; 2016 Nov; 75(5):1022-1031. PubMed ID: 27546292
[TBL] [Abstract][Full Text] [Related]
5. The Skin Cancer Index: quality-of-life outcomes of treatments for nonmelanoma skin cancer.
Sanchez N; Griggs J; Nanda S; Fayne R; Castillo D; De Bedout V; Meirson D; Nichols A
J Dermatolog Treat; 2020 Aug; 31(5):491-493. PubMed ID: 31566077
[No Abstract] [Full Text] [Related]
6. Variation in care for nonmelanoma skin cancer in a private practice and a veterans affairs clinic.
Chren MM; Sahay AP; Sands LP; Maddock L; Lindquist K; Bertenthal D; Bacchetti P
Med Care; 2004 Oct; 42(10):1019-26. PubMed ID: 15377935
[TBL] [Abstract][Full Text] [Related]
7. Review and Update on Evidence-Based Surgical Treatment Recommendations for Nonmelanoma Skin Cancer.
Shelton ME; Adamson AS
Dermatol Clin; 2019 Oct; 37(4):425-433. PubMed ID: 31466583
[TBL] [Abstract][Full Text] [Related]
8. Curettage prior to Mohs' micrographic surgery for previously biopsied nonmelanoma skin cancers: what are we curetting? Retrospective, prospective, and comparative study.
Jih MH; Friedman PM; Goldberg LH; Kimyai-Asadi A
Dermatol Surg; 2005 Jan; 31(1):10-5. PubMed ID: 15720088
[TBL] [Abstract][Full Text] [Related]
9. Laboratory errors leading to nonmelanoma skin cancer recurrence after Mohs micrographic surgery.
Zabielinski M; Leithauser L; Godsey T; Gloster HM
Dermatol Surg; 2015 Aug; 41(8):913-6. PubMed ID: 26218725
[TBL] [Abstract][Full Text] [Related]
10. Variation in care for recurrent nonmelanoma skin cancer in a university-based practice and a veterans affairs clinic.
Clark FL; Sahay A; Bertenthal D; Maddock L; Lindquist K; Grekin R; Chren MM
Arch Dermatol; 2008 Sep; 144(9):1148-52. PubMed ID: 18794460
[TBL] [Abstract][Full Text] [Related]
11. Mohs micrographic surgery vs traditional surgical excision: a cost comparison analysis.
Bialy TL; Whalen J; Veledar E; Lafreniere D; Spiro J; Chartier T; Chen SC
Arch Dermatol; 2004 Jun; 140(6):736-42. PubMed ID: 15210467
[TBL] [Abstract][Full Text] [Related]
12. Mohs appropriate use criteria: retrospectively applied to nonmelanoma skin cancers at a single academic center.
Chong T; Tristani-Firouzi P; Bowen GM; Hadley ML; Duffy KL
Dermatol Surg; 2015 Aug; 41(8):889-95. PubMed ID: 26066619
[TBL] [Abstract][Full Text] [Related]
13. Fee comparisons of treatments for nonmelanoma skin cancer in a private practice academic setting.
Wilson LS; Pregenzer M; Basu R; Bertenthal D; Torres J; Asgari M; Chren MM
Dermatol Surg; 2012 Apr; 38(4):570-84. PubMed ID: 22145798
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of dermoscopy in Mohs micrographic surgery (MMS) for nonmelanoma skin cancer (NMSC).
Yeom SD; Lee SH; Ko HS; Chung KY; Shin J; Choi GS; Byun JW
Int J Dermatol; 2017 Jun; 56(6):e136-e139. PubMed ID: 28247925
[No Abstract] [Full Text] [Related]
15. Recurrence rates of primary nonmelanoma skin cancers treated by surgical excision compared to electrodesiccation-curettage in a private dermatological practice.
Werlinger KD; Upton G; Moore AY
Dermatol Surg; 2002 Dec; 28(12):1138-42; discussion 1142. PubMed ID: 12472494
[TBL] [Abstract][Full Text] [Related]
16. Tumor recurrence of keratinocyte carcinomas judged appropriate for Mohs micrographic surgery using Appropriate Use Criteria.
Stuart SE; Schoen P; Jin C; Parvataneni R; Arron S; Linos E; Boscardin WJ; Chren MM
J Am Acad Dermatol; 2017 Jun; 76(6):1131-1138.e1. PubMed ID: 28365039
[TBL] [Abstract][Full Text] [Related]
17. Risk of synchronous and metachronous second nonmelanoma skin cancer when referred for Mohs micrographic surgery.
Schinstine M; Goldman GD
J Am Acad Dermatol; 2001 Mar; 44(3):497-9. PubMed ID: 11209121
[TBL] [Abstract][Full Text] [Related]
18. Mohs micrographic surgery: a cost analysis.
Cook J; Zitelli JA
J Am Acad Dermatol; 1998 Nov; 39(5 Pt 1):698-703. PubMed ID: 9810885
[TBL] [Abstract][Full Text] [Related]
19. Melanomas of the head and neck have high-local recurrence risk features and require tissue-rearranging reconstruction more commonly than basal cell carcinoma and squamous cell carcinoma: A comparison of indications for microscopic margin control prior to reconstruction in 13,664 tumors.
Fix W; Etzkorn JR; Shin TM; Howe N; Bhatt M; Sobanko JF; Miller CJ
J Am Acad Dermatol; 2021 Aug; 85(2):409-418. PubMed ID: 30458206
[TBL] [Abstract][Full Text] [Related]
20. Association of Tumor Characteristics With Insurance Type Among Patients Undergoing Mohs Micrographic Surgery for Nonmelanoma Skin Cancer.
Clarke EL; Willenbrink TJ; Shelton M; Naeem A; Custer J; Lundgren AD; Boothe WD; Rathouz PJ; Adamson AS; Fox MC; Jambusaria-Pahlajani A
JAMA Dermatol; 2022 Aug; 158(8):919-922. PubMed ID: 35648411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
